China
· Delayed Price · Currency is CNY BGI Genomics Company Description
BGI Genomics Co., Ltd. provides genomic sequencing and proteomic services in China and internationally.
The company offers solutions to various applications, such as basic research covering human, plant, animal, and microbial species; clinical research in human health; genetic testing and screening; drug discovery and development; and agriculture and biodiversity preservation and sustainability.
It provides DNA, RNA, and customized sequencing solutions; and mass spec services, as well as COVID-19 PCR test kits and COVID lab solutions.
In addition, the company offers diagnostics and precision medicines for COVID-19, infectious diseases, and oncology.
It serves academic institutions, pharmaceutical companies, health care providers, and other organizations.
The company was formerly known as Shenzhen BGI Medicine Co., Ltd. and changed its name to BGI Genomics Co., Ltd. in 2015.
BGI Genomics Co., Ltd. was founded in 1999 and is headquartered in Shenzhen, China.
| Country | China |
| Founded | 1999 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 3,752 |
| CEO | Lijian Zhao |
Contact Details
Address: Building No.7 Shenzhen, 518083 China | |
| Phone | 86 755 2527 3120 |
| Website | bgi.com |
Stock Details
| Ticker Symbol | 300676 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003449 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Lijian Zhao | Non Independent Director and GM |
| Yujue Wang | Chief Financial Officer, Deputy GM and Non Independent Director |
| Qian Xu | Director of Legal Affairs, General Counsel, Deputy GM and Secretary |
| Ning Li | Non Independent Director and Deputy GM |
| Zhu Shida | Non Independent Director and Deputy General Manager |
| Weijun Chen | Deputy General Manager |
| Hui Liu | Head of the accounting department and Accounting Supervisor |